Exactly. The management has no good control on costs. If we just look at cv sciences. They have much higher valuation because their sales growth come with much more controllable costs. Their profit grow even faster than revenue, while EXL back to loss with sales growth.
- Forums
- ASX - By Stock
- Ann: Quarterly Report and Appendix 4C
Exactly. The management has no good control on costs. If we just...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EXL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.605M |
Open | High | Low | Value | Volume |
0.5¢ | 0.5¢ | 0.5¢ | $1.605K | 321.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 6265944 | 0.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.6¢ | 14532474 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 3797 | 4.490 |
1 | 8000 | 4.480 |
2 | 6000 | 4.470 |
1 | 358 | 4.460 |
3 | 3424 | 4.450 |
Price($) | Vol. | No. |
---|---|---|
4.500 | 31 | 1 |
4.510 | 342 | 1 |
4.520 | 397 | 1 |
4.530 | 370 | 1 |
4.540 | 825 | 2 |
Last trade - 15.57pm 25/11/2024 (20 minute delay) ? |
Featured News
EXL (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online